Antihypertensive medications and risk of Alzheimer's disease: Evidence for specific medication use

Authors

• Osvaldo J. Laurido-Soto, Washington University School of Medicine in St. Louis
• Alejandra Camacho-Soto, University of Kansas Medical Center
• Irene M. Faust, Barrow Neurological Institute
• Kassu M. Beyene, Barrow Neurological Institute
• Aaron Katz, University of Kansas Medical Center
• Jordan A. Killion, Barrow Neurological Institute
• Brad A. Racette, Washington University School of Medicine in St. Louis

Journal

Alzheimer's & Dementia: Translational Research & Clinical Interventions

Publication Date

2026

Volume

12

Issue

2

First Page

e70242

Document Type

Open Access Publication

DOI

10.1002/trc2.70242

Rights and Permissions

Laurido-Soto OJ, Camacho-Soto A, Faust IM, et al.(202ntihypertensive medications and risk of Alzheimer's disease: Evidence for specific medication use (2026) Alzheimer's & Dementia: Translational Research & Clinical Interventions, 12(2):e70242. https://doi.org/10.1002/trc2.70242 © 2026 The Author(s). Alzheimer's & Dementia: Translational Research & Clinical Interventions published by Wiley Periodicals LLC on behalf of Alzheimer's Association. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

Recommended Citation

Laurido-Soto, Osvaldo J.; Camacho-Soto, Alejandra; Faust, Irene M.; Beyene, Kassu M.; Katz, Aaron; Killion, Jordan A.; and Racette, Brad A., "Antihypertensive medications and risk of Alzheimer's disease: Evidence for specific medication use." Alzheimer's & Dementia: Translational Research & Clinical Interventions. 12, 2. e70242 (2026).
https://digitalcommons.wustl.edu/oa_4/7254

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.